The rationale for starting insulin in this scenario included low body mass index (BMI)/difficulty gaining weight, declining lung function, recurrent pulmonary exacerbations and/or infections, rising HbA1c, and glucose trends (including reactive hypoglycemia, or hyperglycemia during overnight feeds). The gene discussed is INS; the disease is infection.